Biomea Fusion, Inc.BMEANASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank14
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P14
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
PeriodValue
Q3 2025-13.07%
Q2 2025-27.65%
Q1 2025-9.28%
Q4 2024-7.36%
Q3 2024-14.39%
Q2 2024-5.78%
Q1 20249.43%
Q4 202321.77%
Q3 202315.54%
Q2 2023-10.07%
Q1 202318.77%
Q4 202212.59%
Q3 202244.98%
Q2 202210.85%
Q1 20222.36%
Q4 202140.60%
Q3 202150.96%
Q2 202137.55%
Q1 202162.86%
Q4 2020195.56%
Q3 2020265.28%
Q2 2020-35.33%
Q1 20200.00%